This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXMPED2T082_M.jpgClarus (NASDAQ:CLAR) 16% LOWER; reported Q4 EPS of $0.20, $0.18 better than the analyst estimate of $0.02. Revenue for the quarter came in at $104.2 million versus the consensus estimate of $101.12M. The company expects fiscal year 2023 sales of approximately $420M and adjusted EBITDA of approximately $60M, or an adjusted EBITDA margin of 14.3%.
Progyny (NASDAQ:PGNY) 12% HIGHER; reported Q4 EPS of $0.03, $0.02 better than the analyst estimate of $0.01. Revenue for the quarter came in at $214.3M versus the consensus estimate of $211.78M.
Hims & Hers Health Inc (NYSE:HIMS) 10% HIGHER; reported Q4 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $167.2M versus the consensus estimate of $160.8M. Hims & Hers Health, Inc. sees Q1 2023 revenue of $175-180M, versus the consensus of $163M. Adjusted EBITDA of $3M to $6M, reflecting an Adjusted EBITDA margin of 2% to 3%. Hims & Hers Health, Inc. sees FY2023 revenue of $735-755M, versus the consensus of $727M. Adjusted EBITDA of $20M to $30M, reflecting an Adjusted EBITDA margin of 3% to 4%.
Zoom Video Communications Inc (NASDAQ:ZM) 8% HIGHER; reported Q4 EPS of $1.22, $0.41 better than the analyst estimate of $0.81. Revenue for the quarter came in at $1.12 billion versus the consensus estimate of $1.1B. Zoom sees Q1 2024 EPS of $0.96-$0.98, versus the consensus of $0.84. Zoom sees Q1 2024 revenue of $1.08-1.085B, versus the consensus of $1.11B. Zoom sees FY2024 EPS of $4.11-$4.18, versus the consensus of $3.65. Zoom sees FY2024 revenue of $4.435-4.455B, versus the consensus of $4.6B.
AAON Inc (NASDAQ:AAON) (AAON) 4% HIGHER; reported Q4 EPS of $0.71, $0.15 better than the analyst estimate of $0.56. Revenue for the quarter came in at $254.6M versus the consensus estimate of $240.28M.
Workday (NASDAQ:WDAY) 1% LOWER; reported Q4 EPS of $0.99, $0.10 better than the analyst estimate of $0.89. Revenue for the quarter came in at $1.65B versus the consensus estimate of $1.63B.